- Home
- ALGT vs VRDN Comparison
ALGT vs VRDN Comparison
Compare ALGT & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGT
- VRDN
- Stock Information
- Founded
- ALGT 1997
- VRDN 2006
- Country
- ALGT United States
- VRDN United States
- Employees
- ALGT N/A
- VRDN N/A
- Industry
- ALGT Air Freight/Delivery Services
- VRDN Medical Specialities
- Sector
- ALGT Consumer Discretionary
- VRDN Health Care
- Exchange
- ALGT Nasdaq
- VRDN Nasdaq
- Market Cap
- ALGT 1.5B
- VRDN 1.5B
- IPO Year
- ALGT 2006
- VRDN N/A
- Fundamental
- Price
- ALGT $105.30
- VRDN $18.41
- Analyst Decision
- ALGT Hold
- VRDN Buy
- Analyst Count
- ALGT 10
- VRDN 12
- Target Price
- ALGT $83.80
- VRDN $36.44
- AVG Volume (30 Days)
- ALGT 274.2K
- VRDN 1.6M
- Earning Date
- ALGT 02-04-2025
- VRDN 02-25-2025
- Dividend Yield
- ALGT 1.14%
- VRDN N/A
- EPS Growth
- ALGT N/A
- VRDN N/A
- EPS
- ALGT N/A
- VRDN N/A
- Revenue
- ALGT $2,495,886,000.00
- VRDN $302,000.00
- Revenue This Year
- ALGT $2.04
- VRDN $3.30
- Revenue Next Year
- ALGT $12.34
- VRDN N/A
- P/E Ratio
- ALGT N/A
- VRDN N/A
- Revenue Growth
- ALGT N/A
- VRDN N/A
- 52 Week Low
- ALGT $36.09
- VRDN $11.40
- 52 Week High
- ALGT $106.87
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- ALGT 74.73
- VRDN 46.12
- Support Level
- ALGT $101.49
- VRDN $16.60
- Resistance Level
- ALGT $105.15
- VRDN $21.58
- Average True Range (ATR)
- ALGT 4.14
- VRDN 0.98
- MACD
- ALGT 0.36
- VRDN -0.08
- Stochastic Oscillator
- ALGT 91.27
- VRDN 36.35
About ALGT Allegiant Travel Company
Allegiant Travel Co provides travel services in the United States. It sells air transportation on a stand-alone basis or bundled with air-related and third-party services and products. Customers may also purchase fixed-fee flying arrangements to receive charter service on a year-round and ad hoc basis. Additionally, customers may purchase hotel rooms, ground transportation, and other attractions (for example, entertainment show tickets) to accommodate a trip. The company's operating segment includes Airline, Sunseeker Resort, and other non-airlines. Customers purchase travel tickets at airport ticket counters, online, or through its telephone reservation center.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.